About Face: Molecular Aberrations in Head and Neck Mucosal Melanomas

Por Shoushtari, Alexander N.
Publicado no Clin Cancer Res (2019)

PD-1 Blockade in Chinese versus Western Patients with Melanoma

Por Shoushtari, Alexander N., Bao, Riyue, Luke, Jason J.
Publicado no Clin Cancer Res (2020)

Isolated Abducens Nerve Palsy Following Pembrolizumab

Por Jaben, Korey A., Francis, Jasmine H., Shoushtari, Alexander N., Abramson, David H.
Publicado no Neuroophthalmology (2019)

Fibroblast Growth Factor Receptor 3 Amplified Metastatic Melanoma Treated With Erdafitinib

Por Sarkisian, Saro, McIntosh, Alyson, Nair, Suresh, Shoushtari, Alexander N, Callahan, Margaret
Publicado no Cureus (2020)

Primary and metastatic melanoma with NTRK-Fusions

Por Lezcano, Cecilia, Shoushtari, Alexander N., Ariyan, Charlotte, Hollmann, Travis J, Busam, Klaus J
Publicado no Am J Surg Pathol (2018)

Safety and efficacy of ipilimumab to treat advanced melanoma in the setting of liver transplantation

Por Morales, Rita E, Shoushtari, Alexander N, Walsh, Michelle M, Grewal, Priya, Lipson, Evan J, Carvajal, Richard D
Publicado no J Immunother Cancer (2015)

Quality of Life Concerns in Patients with Uveal Melanoma after Initial Diagnosis

Por Barker, Christopher A., Kozlova, Anna, Shoushtari, Alexander N., Hay, Jennifer L., Francis, Jasmine H., Abramson, David H.
Publicado no Ocul Oncol Pathol (2020)

Rates of ERBB2 Alterations across Melanoma Subtypes and a Complete Response to Trastuzumab Emtansine in an ERBB2-Amplified Acral Melanoma

Por Gottesdiener, Lee S., O’Connor, Shannon, Busam, Klaus J., Won, Helen, Solit, David B., Hyman, David M., Shoushtari, Alexander N.
Publicado no Clin Cancer Res (2018)

Indirect Treatment Comparison of Nivolumab Versus Observation or Ipilimumab as Adjuvant Therapy in Resected Melanoma Using Pooled Clinical Trial Data

Por Freeman, Morganna, Betts, Keith A., Jiang, Shan, Du, Ella X., Gupte-Singh, Komal, Lu, Yichen, Rao, Sumati, Shoushtari, Alexander N.
Publicado no Adv Ther (2019)

Combined immunotherapy and radiation for treatment of mucosal melanomas of the lower genital tract()

Por Schiavone, Maria B., Broach, Vance, Shoushtari, Alexander N., Carvajal, Richard D., Alektiar, Kaled, Kollmeier, Marisa A., Abu-Rustum, Nadeem R., Leitao, Mario M.
Publicado no Gynecol Oncol Rep (2016)

Localized Sinonasal Mucosal Melanoma: Outcomes and Associations with Stage, Radiotherapy and PET Response

Por Samstein, Robert M., Carvajal, Richard D., Postow, Michael A., Callahan, Margaret K., Shoushtari, Alexander N., Patel, Snehal G., Lee, Nancy Y., Barker, Christopher A.
Publicado no Head Neck (2016)

Comparative analysis of the GNAQ, GNA11, SF3B1, and EIF1AX driver mutations in melanoma and across the cancer spectrum

Por Johnson, Douglas B., Roszik, Jason, Shoushtari, Alexander N., Eroglu, Zeynep, Balko, Justin, Higham, Catherine, Puzanov, Igor, Patel, Sapna P., Sosman, Jeffrey A., Woodman, Scott E.
Publicado no Pigment Cell Melanoma Res (2016)

Measuring Toxic Effects and Time to Treatment Failure for Nivolumab Plus Ipilimumab in Melanoma

Por Shoushtari, Alexander N., Friedman, Claire F., Navid-Azarbaijani, Pedram, Postow, Michael A., Callahan, Margaret K., Momtaz, Parisa, Panageas, Katherine S., Wolchok, Jedd D., Chapman, Paul B.
Publicado no JAMA Oncol (2017)

DCE-MRI perfusion predicts pseudoprogression in metastatic melanoma treated with immunotherapy

Por Umemura, Yoshie, Wang, Diane, Peck, Kyung K, Flynn, Jessica, Zhang, Zhigang, Fatovic, Robin, Anderson, Erik S, Beal, Kathryn, Shoushtari, Alexander N, Kaley, Thomas, Young, Robert J
Publicado no J Neurooncol (2019)

Checkpoint blockade in melanoma patients with underlying chronic lymphocytic leukemia

Por Smithy, James W., Pianko, Matthew J., Maher, Colleen, Postow, Michael A., Shoushtari, Alexander N., Momtaz, Parisa, Chapman, Paul B., Wolchok, Jedd D., Park, Jae H., Callahan, Margaret K.
Publicado no J Immunother (2021)

A Woman With Metastatic Pancreatic Neuroendocrine Tumor

Por Shoushtari, Alexander N., Covey, Anne M., Zaatari, Ghazi, Shamseddine, Ali, Epstein, Andrew S., Haydar, Ali, Naghy, Mohamed, Mukherji, Deborah, Kelsen, David P., Abou-Alfa, Ghassan K., O'Reilly, Eileen M.
Publicado em 2014

Tolerance and Efficacy of BRAF Plus MEK Inhibition in Patients With Melanoma Who Previously Have Received Programmed Cell Death Protein 1-Based Therapy

Por Saab, Karim R., Mooradian, Meghan, Wang, Daniel Y., Chon, Jeewon, Xia, Cathy Y., Bialczak, Angelica, Abbate, Kelly T., Menzies, Alexander M., Johnson, Douglas B., Sullivan, Ryan J., Shoushtari, Alexander N.
Publicado no Cancer (2018)

Thinking Critically About Classifying Adverse Events: Incidence of Pancreatitis in Patients Treated With Nivolumab + Ipilimumab

Por Friedman, Claire F., Clark, Varina, Raikhel, Andrew V., Barz, Tim, Shoushtari, Alexander N., Momtaz, Parisa, Callahan, Margaret K., Wolchok, Jedd D., Chapman, Paul B., Hellmann, Matthew D., Postow, Michael A.
Publicado no J Natl Cancer Inst (2017)

A Phase 2 Trial of Everolimus and Pasireotide Long Acting Release in Patients with Metastatic Uveal Melanoma

Por Shoushtari, Alexander N., Ong, Leonard T., Schoder, Heiko, Singh-Kandah, Shahnaz, Abbate, Kelly, Postow, Michael A., Callahan, Margaret K., Wolchok, Jedd, Chapman, Paul B., Panageas, Katherine S., Schwartz, Gary K., Carvajal, Richard D.
Publicado no Melanoma Res (2016)

Primary Tumor Volume as a Predictor of Distant Metastases and Survival in Patients with Sinonasal Mucosal Melanoma

Por Flukes, Stephanie, Lohia, Shivangi, Barker, Christopher A., Cracchiolo, Jennifer R., Ganly, Ian, Patel, Snehal G., Roman, Benjamin R, Shah, Jatin P., Shoushtari, Alexander N., Tabar, Viviane S., Shah, Akash, Cohen, Marc A.
Publicado no Head Neck (2020)